Overview

A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine

Status:
Recruiting
Trial end date:
2022-12-09
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the effect of erenumab on medication-specific treatment satisfaction.
Phase:
Phase 4
Details
Lead Sponsor:
Amgen
Treatments:
Erenumab